@pfizer advertised one product on the basis of their well publicized trial and then switched it with a different product with a very different safety profile.

@pfizer advertised one product on the basis of their well publicized trial and then switched it with a different product with a very different safety profile.

But *the process is the product.*

You can’t change the process for making biologics without a new clinical trial. pic.twitter.com/v6dNCKHM50

— Josh Guetzkow (@joshg99) October 3, 2023